Growth Metrics

Baxter International (BAX) Receivables (2016 - 2025)

Baxter International (BAX) has disclosed Receivables for 17 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • On a quarterly basis, Receivables rose 5.86% to $1.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 billion, a 5.86% increase, with the full-year FY2025 number at $1.8 billion, up 5.86% from a year prior.
  • Receivables was $1.8 billion for Q4 2025 at Baxter International, down from $1.9 billion in the prior quarter.
  • In the past five years, Receivables ranged from a high of $2.8 billion in Q2 2024 to a low of $1.6 billion in Q1 2025.
  • A 5-year average of $2.2 billion and a median of $2.3 billion in 2021 define the central range for Receivables.
  • Peak YoY movement for Receivables: skyrocketed 38.97% in 2022, then crashed 36.99% in 2024.
  • Baxter International's Receivables stood at $2.5 billion in 2021, then dropped by 3.59% to $2.4 billion in 2022, then decreased by 28.72% to $1.7 billion in 2023, then fell by 1.88% to $1.7 billion in 2024, then grew by 5.86% to $1.8 billion in 2025.
  • Per Business Quant, the three most recent readings for BAX's Receivables are $1.8 billion (Q4 2025), $1.9 billion (Q3 2025), and $1.9 billion (Q2 2025).